ViewRay Past Earnings Performance
Past criteria checks 0/6
ViewRay's earnings have been declining at an average annual rate of -6.6%, while the Medical Equipment industry saw earnings growing at 9.1% annually. Revenues have been growing at an average rate of 3% per year.
Key information
-6.6%
Earnings growth rate
13.7%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 3.0% |
| Return on equity | -199.8% |
| Net Margin | -104.3% |
| Last Earnings Update | 31 Mar 2023 |
Recent past performance updates
Recent updates
Market Cool On ViewRay, Inc.'s (NASDAQ:VRAY) Revenues Pushing Shares 63% Lower
Apr 17
Health Check: How Prudently Does ViewRay (NASDAQ:VRAY) Use Debt?
Dec 24ViewRay MRI-guided radiation therapy selected by SUNY upstate cancer center
Oct 06ViewRay's MRI-guided radiation therapy gets approval in China
Sep 07ViewRay MRI-guided radiation therapy selected by VA Houston Healthcare System
Aug 23ViewRay: Insider Buying In This $3 Stock
May 15Health Check: How Prudently Does ViewRay (NASDAQ:VRAY) Use Debt?
Apr 22Is ViewRay (NASDAQ:VRAY) Using Debt Sensibly?
Aug 09ViewRay, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 08Read This Before Selling ViewRay, Inc. (NASDAQ:VRAY) Shares
Mar 03How Many ViewRay, Inc. (NASDAQ:VRAY) Shares Do Institutions Own?
Jan 27
ViewRay rallies premarket on Q4 preliminary revenue
Jan 04ViewRay's (NASDAQ:VRAY) Stock Price Has Reduced 56% In The Past Three Years
Dec 22ViewRay +10.6% on CEO acquiring shares
Nov 12Revenue & Expenses BreakdownBeta
How ViewRay makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 23 | 106 | -110 | 83 | 33 |
| 31 Dec 22 | 102 | -107 | 83 | 32 |
| 30 Sep 22 | 88 | -107 | 81 | 33 |
| 30 Jun 22 | 81 | -106 | 77 | 34 |
| 31 Mar 22 | 73 | -109 | 73 | 33 |
| 31 Dec 21 | 70 | -110 | 72 | 32 |
| 30 Sep 21 | 68 | -109 | 70 | 30 |
| 30 Jun 21 | 59 | -112 | 72 | 27 |
| 31 Mar 21 | 58 | -107 | 74 | 25 |
| 31 Dec 20 | 57 | -108 | 77 | 25 |
| 30 Sep 20 | 55 | -117 | 80 | 24 |
| 30 Jun 20 | 66 | -110 | 88 | 25 |
| 31 Mar 20 | 82 | -114 | 93 | 25 |
| 31 Dec 19 | 88 | -120 | 92 | 24 |
| 30 Sep 19 | 92 | -102 | 88 | 21 |
| 30 Jun 19 | 89 | -114 | 81 | 20 |
| 31 Mar 19 | 75 | -105 | 72 | 18 |
| 31 Dec 18 | 81 | -79 | 65 | 17 |
| 30 Sep 18 | 80 | -87 | 59 | 17 |
| 30 Jun 18 | 75 | -65 | 49 | 17 |
| 31 Mar 18 | 59 | -52 | 45 | 16 |
| 31 Dec 17 | 34 | -72 | 40 | 15 |
| 30 Sep 17 | 30 | -59 | 34 | 12 |
| 30 Jun 17 | 18 | -61 | 32 | 11 |
| 31 Mar 17 | 18 | -65 | 30 | 11 |
| 31 Dec 16 | 22 | -51 | 29 | 11 |
| 30 Sep 16 | 11 | -54 | 30 | 12 |
| 30 Jun 16 | 16 | -50 | 28 | 12 |
| 31 Mar 16 | 16 | -50 | 29 | 12 |
| 31 Dec 15 | 10 | -45 | 27 | 10 |
| 30 Sep 15 | 6 | -41 | 26 | 9 |
| 30 Jun 15 | 4 | -38 | 25 | 9 |
| 31 Mar 15 | 5 | -34 | 20 | 9 |
| 31 Dec 14 | 6 | -34 | 19 | 9 |
| 30 Sep 14 | 8 | -32 | 16 | 10 |
| 31 Dec 13 | 3 | -28 | 13 | 9 |
| 31 Dec 12 | 2 | -25 | 10 | 8 |
Quality Earnings: VRAY.Q is currently unprofitable.
Growing Profit Margin: VRAY.Q is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VRAY.Q is unprofitable, and losses have increased over the past 5 years at a rate of 6.6% per year.
Accelerating Growth: Unable to compare VRAY.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VRAY.Q is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.7%).
Return on Equity
High ROE: VRAY.Q has a negative Return on Equity (-199.82%), as it is currently unprofitable.